|Current||NAV||Change $||Change %||POP|
As of: 12/31/2019
|Year To Date||One Year||Three Years||Five Years||Ten Years||Since Inception|
The average annual returns in the table reflect the maximum sales charge of 4.25%.
|2.985% (subsidized)||2.273% (unsubsidized)|
|Reinvest Date||Dividend||STCG||LTCG||Return of Capital|
|Distribution and Service (12b-1) Fees||1.00%|
|Total Annual Fund Operating Expenses||2.48%|
|Fee Waivers and Expense Reimbursements||-0.84%|
|Total Annual Fund Operating Expenses (After Fee Waivers and Expense Reimbursements)||1.64%|
1.00% CDSC on any Class C Shares redeemed within one year of purchase.
0.00% CDSC on any Class C Shares redeemed within one year of purchase.
The full quarterly holdings report can be found by viewing the
|HCA INC 5.375% 2/1/2025|
|SPRINT CAP CORP 8.75% 3/15/2032|
|DISH DBS CORP 5.875% 11/15/2024|
|CCO HOLDINGS LLC 5.125% 5/1/2027|
|CSC HOLDINGS LLC 10.875% 10/15/2025|
|ARDAGH PKG FIN 6% 2/15/2025|
|VALEANT PHARMA 6.125% 4/15/2025|
|VICI Properties, Inc|
|SPRINT CORP 7.625% 2/15/2025|
|CCO HOLDINGS LLC 5.875% 4/1/2024|
|INFOR US INC 6.5% 5/15/2022|
|VALEANT PHARMA 9% 12/15/2025|
|HCA INC 5.875% 2/15/2026|
|TENET HEALTHCARE 4.875% 1/1/2026|
|DISH DBS CORP 5% 3/15/2023|
The mutual funds referred to in this website are offered by Prospectus only. For more complete information an investor should consider the investment objectives, risks, and charges and expenses of the investment company carefully before investing. The prospectus contains this and other information about the investment company. You may obtain a prospectus and summary prospectuses at no cost from your financial adviser. Please read the prospectus carefully before investing.
The performance data quoted represents past performance. Past performance does not guarantee future results. The Fund’s principal value, share price, yields, rates and total returns will vary due to changing market conditions, so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. To obtain performance data current to the most recent month-end, an investor may call toll free at 800-276-1262.
Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.
High yield securities are lower-quality debt securities and are subject to greater risk of default or price changes due to changes in the credit quality of the issuer. Bond funds generally decline in value as interest rates rise.
Diversification does not assure a profit or protect against loss in a declining market.
SMH Capital Advisors, Inc. served as investment adviser to the Fund from April 30, 2004 through May 4, 2008. Effective May 5, 2008, JPMorgan is the sub-advisor to Integrity High Income Fund. Following a shareholder confirmation process, on September 10, 2008, JPMorgan was approved as sub-advisor to Integrity High Income Fund.
Morningstar Ratings: For each fund with at least a 3-year history, Morningstar calculates a risk-adjusted return measure that accounts for variation in a fund's monthly performance (excluding sales charges and including fees and expenses versus all funds in the Morningstar category), placing more emphasis on downward variations and rewarding consistent performance. These ratings change monthly. The top 10% of funds in each category receive a Morningstar Rating™ of 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund and rated separately.) Past performance does not guarantee future results. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.